Nebenwirkungen · Vectibix
Vectibix 20 mg/mL concentrate for solution for infusion. · Abschnitt 4.8 · PDF-Seite 8
HOS-117402 · Präparat HOS-094601
Adverse reactions MedDRA Very common Common Uncommon system organ (≥ 1/10) (≥ 1/100 to < 1/10) (≥ 1/1 000 to class < 1/100) Infections and Conjunctivitis Rash pustular Eye infection infestations Paronychia1 Cellulitis1 Eyelid infection Urinary tract infection Folliculitis Localised infection Blood and Anaemia Leucopenia lymphatic system disorders Immune system Hypersensitivity1 Anaphylactic disorders reaction2 Metabolism and Hypokalaemia Hypocalcaemia nutrition Hypomagnesaemia Dehydration disorders Decreased appetite Hyperglycaemia Hypophosphataemia Psychiatric Insomnia Anxiety disorders Nervous system Headache disorders Dizziness Eye disorders Blepharitis Ulcerative Growth of eyelashes keratitis1,4 Lacrimation increased Keratitis1 Ocular hyperaemia Eyelid irritation Dry eye Eye pruritus Eye irritation Cardiac Tachycardia Cyanosis disorders Vascular Deep vein thrombosis disorders Hypotension Hypertension Flushing Respiratory, Dyspnoea Pulmonary embolism Interstitial lung thoracic and Cough Epistaxis disease3 mediastinal Bronchospasm disorders Nasal dryness
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-05-07T10:43:00Z · SHA-256 623c963b5fb57ad899208d5b3acaf4f91d25565ad9b26d6ae5a16bcb53a34569 · Passage 8931247abae5ba3f543eec315ab9aee191b692321ed2ed8eaca9525edc543677 · Zeichen 1525–4271 im Abschnitt